Hamilton Lane Incorporated HLNE
89.46 USD -0.67 (-0.74%)
At closeNov 6, 2026, 4:00 PM EST
89.46 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
88.95 Day range 91.77
71.88 52-week range 155.66
- YTD
- -33.39%
- 1 year
- -30.03%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 123.63 +38.2% upside
Now 89.46
- Target (low)
- 95.00
- Target (mean)
- 123.63
- Target (high)
- 170.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy2
- Buy5
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.76 | 1.57 – 1.93 | 1.55 | +13.5% | 237.80M | +19.8% | 4 |
| Next quarter | 1.87 | 1.61 – 1.99 | 1.49 | +25.5% | 244.03M | +26.1% | 4 |
| Current year | 7.65 | 7.37 – 7.83 | 5.90 | +29.7% | 953.81M | +25.7% | 3 |
| Next year | 7.44 | 7.20 – 7.72 | 7.65 | -2.8% | 1.06B | +11.3% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2026 | UBS | Maintained | Buy | Buy |
| Nov 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 4, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Oct 27, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Oct 13, 2026 | UBS | Maintained | Buy | Buy |
| Oct 2, 2026 | Wells Fargo | Initiated | — | Overweight |
| Aug 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 5, 2026 | UBS | Maintained | Buy | Buy |
| Aug 5, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jul 21, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 17, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 10, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jun 30, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jun 18, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| May 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| May 22, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| May 18, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 21, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 16, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Apr 13, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 24, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 20, 2026 | UBS | Maintained | Buy | Buy |
| Feb 4, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 4, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jan 13, 2026 | UBS | Maintained | Buy | Buy |
| Jan 8, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Dec 17, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Nov 6, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
